Eli Lilly (LLY): The GLP-1 Trade Is Bigger Than the Market Thinks
Mounjaro up 125%. Zepbound up 79%. A new oral pill just launched. The growth story keeps widening.
Mounjaro up 125%. Zepbound up 79%. A new oral pill just launched. The growth story keeps widening.
A single analyst call rewired how Wall Street thinks about memory chips — and MU hasn't looked back.
Eli Lilly's Q1 blowout reset the ceiling — and the options flow is telling a very specific story
Custom silicon, record revenue, and a $100B runway — this is not your average chip story.
The biggest put buying eruption in TLT in recent memory just happened. This is not a drill.